OSCIENT PHARMACEUTICALS CORP (OSCI) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 150 transactions totaling $2.0M, demonstrating a bearish sentiment with -$1.8M in net insider flow. The most recent transaction on May 21, 2009 involved a sale of 785,616 shares valued at $235.7K.
No significant insider buying has been recorded for OSCI in the recent period.
No significant insider selling has been recorded for OSCI in the recent period.
Based on recent SEC filings, insider sentiment for OSCI is bearish with an Insider Alignment Score of 5/100 and a net flow of -$1.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at OSCIENT PHARMACEUTICALS CORP (OSCI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading OSCI stock, having executed 150 transactions in the past 90 days. The most active insider is Gary Patou (Executive), who has made 22 transactions totaling $521.6K.
Get notified when executives and directors at OSCI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 21, 2009 | Inc. Glg Partners, | Executive | Sale | 785,616 | $0.30 | $235.7K | |
| May 15, 2009 | Ventures I. Llc Mpm Bio | Executive | Conversion | 4,222 | $1.10 | $4.6K | |
| May 14, 2009 | Management, Llc Dellacamera Capital | Executive | Sale | 468,230 | $0.21 | $98.3K | |
| May 13, 2009 | Management, Llc Dellacamera Capital | Executive | Sale | 108,162 | $0.23 | $24.9K | |
| May 13, 2009 | Management, Llc Dellacamera Capital | Executive | Sale | 416,391 | $0.25 | $104.1K | |
| May 11, 2009 | Management, Llc Dellacamera Capital | Executive | Conversion | 992,783 | $N/A | $0 | |
| May 8, 2009 | Management, Llc Dellacamera Capital | Executive | Sale | 100,325 | $0.27 | $27.1K | |
| Apr 1, 2009 | Management, Llc Dellacamera Capital | Executive | Sale | 70,000 | $0.13 | $9.1K | |
| Mar 31, 2009 | Management, Llc Dellacamera Capital | Executive | Sale | 150,000 | $0.13 | $19.5K | |
| Mar 27, 2009 | Management, Llc Dellacamera Capital | Executive | Sale | 200,000 | $0.13 | $26.0K | |
| Mar 26, 2009 | Management, Llc Dellacamera Capital | Executive | Sale | 160,269 | $0.13 | $20.8K | |
| Mar 25, 2009 | Management, Llc Dellacamera Capital | Executive | Sale | 967,939 | $0.18 | $174.2K | |
| Jul 28, 2008 | A. Glickman Mark | Executive | Award | 10,000 | $N/A | $0 | |
| Jun 12, 2008 | K. Stone David | Executive | Award | 300 | $N/A | $0 | |
| Jun 12, 2008 | G. Riedel Norbert | Executive | Award | 300 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 73 | $1.9M | 92.4% |
Purchase(P) | 14 | $90.5K | 4.4% |
Other(J) | 5 | $38.7K | 1.9% |
Exercise(M) | 12 | $22.6K | 1.1% |
Conversion(C) | 2 | $4.6K | 0.2% |
Award(A) | 40 | $0 | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Insider selling pressure at OSCIENT PHARMACEUTICALS CORP has increased, with 21 insiders executing 150 transactions across all time. Total sales of $1.9M significantly outpace purchases of $90.5K, resulting in a net outflow of $1.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.